Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$0.69 - $1.21 $23,184 - $40,656
-33,600 Reduced 98.2%
616 $1,000
Q1 2022

May 05, 2022

BUY
$1.02 - $3.8 $141 - $528
139 Added 0.41%
34,216 $41,000
Q4 2021

Feb 02, 2022

SELL
$3.26 - $4.66 $661 - $945
-203 Reduced 0.59%
34,077 $111,000
Q3 2021

Nov 02, 2021

BUY
$4.08 - $5.66 $1,105 - $1,533
271 Added 0.8%
34,280 $153,000
Q2 2021

Aug 02, 2021

BUY
$5.01 - $7.48 $2,049 - $3,059
409 Added 1.22%
34,009 $185,000
Q1 2021

May 11, 2021

BUY
$7.19 - $14.95 $32,355 - $67,275
4,500 Added 15.46%
33,600 $251,000
Q4 2020

Feb 08, 2021

SELL
$6.66 - $14.66 $75,258 - $165,658
-11,300 Reduced 27.97%
29,100 $316,000
Q2 2020

Aug 07, 2020

BUY
$5.21 - $11.03 $47,411 - $100,373
9,100 Added 29.07%
40,400 $431,000
Q1 2020

May 06, 2020

BUY
$4.46 - $9.2 $892 - $1,839
200 Added 0.64%
31,300 $186,000
Q4 2019

Feb 05, 2020

SELL
$4.52 - $10.1 $18,984 - $42,420
-4,200 Reduced 11.9%
31,100 $215,000
Q2 2019

Aug 09, 2019

BUY
$5.5 - $9.75 $45,100 - $79,950
8,200 Added 30.26%
35,300 $327,000
Q2 2018

Aug 10, 2018

BUY
$10.16 - $13.65 $139,192 - $187,005
13,700 Added 102.24%
27,100 $277,000
Q2 2017

Aug 11, 2017

BUY
N/A
13,400
13,400 $216,000

About Syros Pharmaceuticals, Inc.


  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.